Disulfiram induced a decrease in MLL1 protein levels in all tested cells, indicating that the findings from the drug screening in leukemia cells are transferable to pediatric glioma cells (Fig. 2A–E, conditions 1–4). This evidence concerns the gene KMT2A and leukemia.